Sunday, February 04, 2007

Making tough choices in biotechnology

Making tough choices in biotechnology
By George Elvin
“The ongoing political debate over the appropriate use of embryonic stem cells and the low level of government support have denied stem cell research the catalyst provided to biotechnology,” say the article’s authors. ...



"Smokable" pain drugs promise faster action By Oceaneyes2 Alexza was formed by biotechnology entrepreneur Alejandro Zaffaroni, who also founded nicotine-patch developer Alza. His latest venture is not the only company that is developing inhaled therapies: Nektar Therapeutics and Alkermes Inc. ...



Deadline Extended for Innovation Corridor Submissions at the 2007 ...
... Extended for Innovation Corridor Submissions at the 2007 BIO International Convention http://digital50.com/news/items/CT/2001/07/14/20070202005571/deadline-
extended-for-innovation-corridor-submissions-at-the-2007-bio-international. ...

ADN1.COM Category: Biotechnology


Weblog Awards

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home